pbyi-def14a_20210615.htm
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer - Puma Biotechnology (NASDAQ:PBYI) - Benzinga
Puma Biotechnology
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology, Inc. (PBYI) Stock Price, Quote & News - Stock Analysis
printmgr file
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Puma Biotechnology
Puma Biotechnology (Nasdaq:PBYI) - Stock Price, News & Analysis - Simply Wall St
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
HCW starts Puma Biotechnology at buy; PT $15 - BioTuesdays
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Puma Biotechnology
Does Puma's quick Nerlynx launch play into its buyout prospects? | Fierce Pharma
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Seen as Takeover Target After Strong Cancer Drug Data - TheStreet
Is Puma Biotechnology a Buy? | The Motley Fool
PUMA BIOTECHNOLOGY, INC. FORM 8-K/A - Shareholder.com
Articles with Puma Biotechnology
Puma Biotechnology Stock (NASDAQ:PBYI), Quotes and News Summary - Benzinga
Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity - Market Exclusive
Here's Why Puma Biotechnology Tumbled Today | The Motley Fool
Puma Biotechnology Inc (PBYI) Stock: Do Analysts Think You Should Sell?
PUM Stock Forecast, Price & News (Puma)
